The DRBD13 RNA binding protein is involved in the insect-stage differentiation process of Trypanosoma brucei  by Jha, Bhaskar Anand et al.
FEBS Letters 589 (2015) 1966–1974journal homepage: www.FEBSLetters .orgThe DRBD13 RNA binding protein is involved in the insect-stage
differentiation process of Trypanosoma bruceihttp://dx.doi.org/10.1016/j.febslet.2015.05.036
0014-5793/ 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Author contributions: BAJ, VHG, CWP, and RS designed research; BAJ, VHG, and CWP
performed research; BAJ, VHG, CWP, and RS analyzed data; BAJ, VHG, and RS wrote
the paper.
⇑ Corresponding author. Fax: +1 514 398 7857.
E-mail address: reza.salavati@mcgill.ca (R. Salavati).
1 These authors have equal contribution to this study.Bhaskar Anand Jha 1, Vahid H. Gazestani 1, Chun Wai Yip, Reza Salavati ⇑
Institute of Parasitology, McGill University, 21,111 Lakeshore Road, Ste. Anne de Bellevue, Quebec H9X3V9, Canada
a r t i c l e i n f oArticle history:
Received 15 February 2015
Revised 21 April 2015
Accepted 20 May 2015
Available online 28 May 2015
Edited by Michael Ibba
Keywords:
DRBD13
Post transcriptional gene regulatory
program
Insect stage differentiation process
Trypanosoma bruceia b s t r a c t
DRBD13 RNA-binding protein (RBP) regulates the abundance of AU-rich element (ARE)-containing
transcripts in trypanosomes. Here we show that DRBD13 regulates RBP6, the developmentally
critical protein in trypanosomatids. We also show DRBD13-speciﬁc regulation of transcripts
encoding cell surface coat proteins including GPEET2, variable surface glycoprotein (VSG) and
invariant surface glycoprotein (ISG). Accordingly, alteration in DRBD13 levels leads to changes in
the target mRNA abundance and parasite morphology. The high consistency of the observed
phenotype with known cell membrane exchanges that occur during progression of T. brucei through
the insect stage of its life cycle suggests that DRBD13 is an important regulator in this largely
unknown developmental process.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Trypanosoma brucei is a unicellular protozoan parasite and the
causative agent of sleeping sickness in humans and nagana in cat-
tle [1]. The parasite is transmitted between different mammalian
hosts by an insect vector ‘‘tse-tse ﬂy’’ [2]. To complete its life cycle
in the two hosts, trypanosomes go through several morphological
and molecular changes in response to the changing conditions
[2,3]. In the insect vector for instance, trypanosomes encounter
and adapt to different environments in the ﬂy midgut, proventricu-
lus and ﬁnally in the salivary glands [4]. Two of the predominant
developmental forms cultured in laboratory are blood-stream form
(BS; residing in the mammalian host) and procyclic form (PC; in
the insect vector). While the cell surface of BS is covered with
VSG [5] and less abundant ISGs [6,7], PC trypanosomes are coated
with family of glycoproteins called procyclins [8]. During differen-
tiation from PC to BS, trypanosomes reacquire the VSG coat and
lose their procyclins in the ﬂy salivary gland at a stage termed
metacyclic (MC; the only infective form in trypanosome life cycle)
[3,4]. Although trypanosomes are very successful in adapting tochanging conditions in different hosts, the parasites have almost
no transcriptional control of gene expression and heavily rely on
the post-transcriptional gene regulation [9]. Interaction between
the cis regulatory elements in the 30 untranslated region (UTR) of
mRNAs and the trans acting RBPs are indispensable for this kind
of regulation [10,11]. In higher eukaryotes, several ARE binding
proteins (AUBPs), with multiple regulatory roles on the ARE
containing mRNAs, have been discovered. While some of them
stabilize ARE containing transcripts [12,13], others can mediate
degradation [14–17] or translational repression of their
ARE-containing target RNAs [18,19]. In case of trypanosomes, our
lab previously reported the presence of AREs in the 30UTR of devel-
opmentally regulated mRNAs and found three putative AUBPs that
regulate the fate of these ARE-containing transcripts [20]. Here, we
have characterized one of these three AUBPs, called DRBD13,
which contains two RNA recognition motifs (RRMs) [21]. We show
that the tagged DRBD13 is localized in the cytoplasm of PC
trypanosomes. DRBD13 level is tightly regulated in the PC stage,
as DRBD13-myc over-expression as well as DRBD13 RNAi is
deleterious to the parasite’s growth. Analysis of data obtained from
three high throughput experiments on this protein, suggested the
regulatory role of DRBD13 protein on transcripts that encode cell
membrane proteins. Consistently, both DRBD13 RNAi and an ecto-
pic expression of tagged DRBD13 led to changes in the expression
level of membrane associated proteins and, accordingly, severe
changes in the parasite’s cell morphology. Additionally, the
RIP-seq data suggested binding of the RBP6 transcript to DRBD13
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stage of life cycle has already been demonstrated [22]. Here we
show that DRBD13 RNAi leads to an up-regulation of RBP6 mRNA.
These results highlight the importance of DRBD13 as a necessary
factor for normal growth of the insect form of trypanosomes and
the protein’s potential involvement in the developmental process
of the parasite in the ﬂy.
2. Materials and methods
2.1. Trypanosome culture
Culturing and transfection of trypanosomes (Lister 427 strain
expressing the tetracycline (tet) repressor from pHD1313 and
29–13) were performed as described in [20].
2.2. Plasmid constructs
Oligonucleotides and plasmids prepared for this study are listed
in Tables 1 and 2, respectively. For ectopic over-expression in
1313-PC cells, DRBD13 ORF was cloned in pHD1700 (C-terminal
myc tagging; HindIII and HpaI) and pHD1701 (N-terminal myc
tagging; ApaI and BamHI), followed by linearization by NotI and
transfection [23]. For tethering experiments DRBD13 ORF was
cloned in pHD1743 (ApaI and BamHI) [24], so that the resulting
plasmid encoded a fusion protein, kN-DRBD13-myc. The linearized
plasmid was transfected into two different cell lines constitutively
expressing CAT (chloramphenicol acetyl transferase) reporter lack-
ing, and harboring, ﬁve copies of the kN-peptide recognition site
‘‘boxB’’ – in its 30UTR (pHD1991 and pHD2277, respectively) [24].
2.3. Indirect immunoﬂuorescent staining and Western blotting
For immunoﬂuorescent assay, the steps of slide preparation
were performed as previously described [25], and the images wereTable 1
Primers used in this study.
Primer name Primer seq
DRBD13_Nmyc_Fw agctgggcccTGACAG
DRBD13_Nmyc_Rev agctggatccTCAACCT
DRBD13_Cmyc_Fw agctaagcttATGACAG
DRBD13_Cmyc_Rev agctgttaacACCTACA
DRBD13_tethering_Fw agctgggcccATGACAG
DRBD13_tethering_Rev agctggatccACCTACA
Splice leader Fw GACTAGTTTCTGTAC
VSG 30UTR reverse CCGGGTACCGTGTT
ISG Fw CAGGTGGAAGTTGG
ISG Rev TCCTTATTTACACTC
GPI-PLC Fw CTCTGCTGCGTTTGT
GPI-PLC Rev TTTCAAACACCGTCC
DRBD13_Probe_Fw GCAACCTCTTCATAT
DRBD13_Probe_Rev CGCCTGCTTACCAGA
RBP6_Probe_Fw CAACAGCCGTATCA
RBP6_Probe_Rev ACTCATTCGCTCCAC
CAT_Probe_Fw ATCCCAATGGCATCG
CAT_Probe_Rev ATCACAGACGGCAT
Fw: forward primer; Rev: reverse primer.
Restriction sites are underlined; complementary sequences of primers are
Table 2
Plasmids used in this study.
Plasmid name Description
C-myc DRBD13 Ectopic over-expression of DRBD13-myc; pHD1700 + DRB
N-myc DRBD13 Ectopic over-expression of myc-DRBD13; pHD1701 + DRB
DRBD13 tethering Ectopic expression on kN-DRBD13-myc; pHD1743 + DRB
pHD1991 Reporter vector without boxB (recognition sequence for
pHD2277 Reporter vector with ﬁve boxB (recognition sequence fortaken using the Nikon eclipse E800 microscope. For Western blot-
ting, we used: anti-myc (Life technologies, #A21280), anti-CAT
(Sigma, #C9336) and antibodies against the small ribosomal
subunit protein S9 and phosphoglycerate kinase (PGK).
2.4. Northern blotting
Parasites were harvested and RNA was prepared using Trizol
reagent (Ambion, CA, USA). Total RNA (10 lg) was run on a
denaturing formaldehyde gel, followed by blotting. DNA probes
(see Table 1 for PCR primers) were prepared using the Prime-IT
Random Primer Labeling Kit (Stratagene) and hybridized at 65 C.
2.5. Semi-quantitative reverse transcription PCR
RNA was treated with DNase using Turbo DNA-free Kit (Life
Technologies, AM1907). cDNAs were prepared from 4.5 lg RNA
using random hexamers and Taqman Reverse transcription
reagents (Life Technologies, N8080234) in a 30 lL reaction; subse-
quently diluted 5-fold in water (120 lL H2O). Control reactions
without reverse transcriptase (RT) were used to conﬁrm
elimination of genomic DNA contamination. Semi-quantitative
PCR was performed in a 20 lL reaction containing 50 ng of cDNA,
1 GoTaq Green Master Mix (Promega, M712), and 1 lM of each
forward and reverse primers, (primers described in [22]). The
PCR reactions were visualized on a 1% agarose gel.
2.6. Cell fractionation and polysome puriﬁcation
Tetracycline was added to approximately 100 mL of
1313-DRBD13-myc PC trypanosomes growing at a density of
5  106 cells/mL. After 3 h of DRBD13-myc induction, the cells
were fractionated as described in [26] followed by polysome
preparation as in [27]. Western blots were incubated in antibodies
against myc tag and small ribosomal subunit protein S9.Restriction site
ACCACCAAGTCATCTGC ApaI
ACACGCATGGTGGGA BamHI
ACCACCAAGTCATCT HindIII
CGCATGGTGGGAGTC HpaI
ACCACCAAGTCATCT ApaI
CGCATGGTGGGAGTC BamHI
TAT [22]
AAAATATATC [22]
TATTGA
GCTGT
GACTG
CCCTC
CGGGA
AGAAC
TCCCTT
AGCTT
TAAAG
GATGAA
in uppercase.
Restriction sites
D13 [23] HindIII/HpaI
D13 [23] ApaI/BamHI
D13 [24] ApaI/BamHI
k peptide) in the 30UTR downstream of CAT ORF [24]
k peptide) in the 30UTR downstream of CAT ORF [24]
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3.1. Identifying the direct targets of DRBD13
The DRBD13 protein (Tb927.8.6650) is 666 amino acids (aa)
long, and has an RNA binding region containing two closely located
RRM domains (Fig. 1A). Interestingly, the 50 and 30 ﬂanking
sequences of the RNA binding region (270aa and 200aa long,
respectively) are unique to T. brucei subspecies and cannot be
found in other trypanosomatid organisms, suggesting its unique
function/interacting partners in T. brucei. Previous reports have
demonstrated the functionality of DRBD13 protein in the PC life
stage of the organism [20] and its upregulation in the stationary
phase (stationary phase presumably resembles the metacyclic life
stage of the parasite) [28]. As a ﬁrst step towards determining
the DRBD13 mRNA targets, we re-analyzed the data obtained from
three high-throughput experiments on the RBP (Fig. 1B): (1) tran-
scriptome changes in response to DRBD13 over-expression; (2)
transcriptome changes in response to DRBD13 depletion; and (3)
high-throughput sequencing of transcripts co-puriﬁed with
DRBD13 tandem afﬁnity puriﬁcation (RIP-seq) [20]. Due to the
complementary nature of these approaches, their integration leads
to the removal of false positive results (e.g., secondary/indirect
effects) and gaining of a thorough picture on the biological function
and direct targets of the protein under investigation. Analysis of
the transcriptome data suggested that DRBD13 acts as a negative
regulator of transcripts encoding ribosomal and cell membrane
proteins and the proteins involved in transport (Fig. 1C).
Additionally, the analysis of RIP-seq data indicated that DRBD13
preferentially associates with the transcripts encoding cell mem-
brane associated proteins and also proteins involved in the(C)
(A) (B
Fig. 1. Sequence and functional characteristics of DRBD13 RBP. (A) DRBD13 protein has a
to T. brucei sspp. (B) Clustered RNAseq data of 29–13 wild type cells (WT), DRBD13 knoc
transcripts aligned (transcripts with greater than ﬁvefold enrichment in the bound frac
speciﬁcally, details of changes in RBP6 transcript expression in response to DRBD13 over
experiment is shown at the bottom of heat map. (C) Gene ontology (GO) enrichment anal
GO analysis was performed by applying Wilcoxon–Mann–Whitney ranked sum test on
Figure is pseudo-colored, with only signiﬁcant GO terms shown. For the transcriptome da
transcriptome datasets (P-value <0.05); (2) their pattern (i.e., over-/under-representation
the considered cut-off threshold was the false discovery rate <0.05.post-translational modiﬁcations (Fig. 1C). RIP-seq data also
demonstrated that RBP6 (Tb927.3.2930) mRNA is highly enriched
in the DRBD13 bound fraction (18-fold enrichment relative to
the control, whole cell lysate) (Fig. 1B). Interestingly, AREs can be
found in the 30UTR of RBP6mRNA itself which is in agreement with
the interaction of DRBD13 with AREs in the 30UTR of targeted
mRNAs. Together, these data indicate that DRBD13 binds and
potentially regulate transcripts encoding surface coat proteins
and RBP6 mRNA.
3.2. DRBD13 is a cytoplasmic protein and changes in its expression
level has severe effects on the cell morphology
To localize DRBD13 in PC trypanosomes, we generated two cell
lines expressing N-terminal or C-terminal myc-tagged DRBD13. In
both cell lines, DRBD13 was ectopically expressed and localized
after 24 h of induction (Fig. 2A). Myc-tagged DRBD13 was absent
from the nucleus and showed a homogenous distribution in the
cytoplasm. Consistent with these results, Western analyses
showed the expression of tagged protein after 24 and 48 h of tet
induction, which was absent in wild type (WT) or uninduced
(-tet) control cell lines (Fig. 2B).
To examine the effect of DRBD13 expression on PC try-
panosomes over time, we ectopically expressed the C-terminal
myc-tagged DRBD13. We could detect the expression of DRBD13
on a Western blot only after 3 h of induction by tet addition
(Fig. 3B). Two days after induction of DRBD13 expression, we
observed slower growth rate as compared to the -tet or WT cells
(Fig. 3A). Similar slow growth was observed with N-terminal
myc-tagged protein (not shown). Additionally, majority of cells
showed changes in morphology after 24 h of induction of both C)
conserved RNA binding region surrounded by two ﬂanking regions that are unique
kdown (RNAi) or over-expression (OE) presented in a heat map with RIPseq bound
tion compared to control experiment were considered as bound transcripts). More
-expression and knock-down along with its fold enrichment in the DRBD13 RIPseq
ysis of knockdown, over-expression, and RIPseq results using GOstat web server. The
the ranked lists of transcripts sorted according to their fold changes/enrichments.
ta, GO terms were considered as signiﬁcant if: (1) they were enriched in both of the
) were opposite in the RNAi and over-expression experiments. For the RIP-seq data,
Fig. 2. Localization of DRBD13-myc. (A) N terminal and C terminal myc-tagged DRBD13 expressing cells were used for immunoﬂuorescence experiments. Anti-myc antibody
was used to detect DRBD13-myc. Rows 1 and 3 (from top) show a cytoplasmic localization of the tagged protein after 24 h of induction by tetracycline (tet). Rows 2 and 4
(from top) show signals from the -tet cells. The bottom row shows signal from procyclic wild type trypanosomes (WT PC; without the transfected plasmid). DRBD13-myc
stands for myc-tagged DRBD13; DAPI was used to stain nuclei and kinetoplasts. (B) Western blot showing the induction of the myc-tagged DRBD13 after 24 and 48 h of
induction by tet (‘’ uninduced; ‘+’ induced). WT– wild type cells; PGK – phosphoglycerate kinase (loading control).
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not show an apparent cytokinesis defects, as evident from the
DAPI-stained nuclei and kinetoplast (Fig. 2A). The effect of
DRBD13 over-expression on the cell phenotype and growth was
reversible, i.e. once DRBD13-myc over-expression was diminished,
the trypanosome morphology and growth became normal.
Moreover, the growth recovery of the over-expressing cells afterday 3 was directly correlated with the decrease in DRBD13 ectopic
expression from day 3 onwards (Fig. 3B). These data suggest that
the normal level of DRBD13 is in fact crucial for the cells.
A more dramatic effect of knockdown on cell growth was
observed at a later time point as compared to the effect seen after
over-expression of DRBD13. Knockdown of DRBD13 following RNAi
induction after 3 days was lethal to the PC cells (Fig. 3A). The effect
Fig. 3. DRBD13 is an essential protein for normal growth of the procyclic trypanosomes. (A) Growth curve of PC trypanosomes after DRBD13 over-expression and RNAi.
Number of days after induction by tet addition have been plotted on x-axis while y-axis shows cumulative cell number. Growth defects arising after RNAi and over-expression
can easily be seen. It should be noted that the cells recover from growth defect arising after DRBD13 over-expression, while DRBD13 RNAi is lethal in PC trypanosomes. (B)
Western blot showing the expression of DRBD13-myc (C terminal) after tet induction. The ectopic expression of the tagged protein can be seen after 3 h of induction.
Figure depicts time in ‘hours (h)’ for the ﬁrst few lanes and in ‘days’ for the next lanes. By day 7, expression of the DRBD13-myc is completely diminished. Comparison with
Fig. A shows that rescue from growth defect in over-expression cell line follows similar pattern as the down-regulation of DRBD13-myc. PGK serves as a loading control. WT –
wild type; ‘’ uninduced; ‘+’ induced. (C) Northern blot showing DRBD13 RNAi. Although RNAi does not seem to be completely efﬁcient, it is enough to cause a lethal effect in
PC trypanosomes. Histone H4 (H4) mRNA was probed as a loading control. WT- wild type; ‘’ uninduced; ‘+’ induced.
1970 B.A. Jha et al. / FEBS Letters 589 (2015) 1966–1974of knockdown was observed at the DRBD13 transcript level after
3 h (Fig. 3C). Induction of DRBD13 RNAi also affected trypanosome
morphology (not shown).
These results suggest the existence of tight regulation on
DRBD13 expression levels in trypanosomes. They also support the
putative role of DRBD13 RBP in the regulation of membrane asso-
ciated proteins.
3.3. Down-regulation or up-regulation effect of DRBD13 on RBP6
mRNA
To examine the effects of DRBD13 expression changes on its tar-
get mRNAs and experimentally validate the predicted targets, we
used DRBD13 RNAi and over-expression cell lines and monitored
RBP6mRNA levels by Northern blotting (Fig. 4). There was a notice-
able effect of DRBD13 RNAi on RBP6 mRNA expression. After 6 h of
induction of DRBD13 RNAi, the decrease in DRBD13mRNA parallels
an increase in RBP6mRNA level, which further increased after 24 h
by 10-fold compared to the WT or uninduced cell lines (Fig. 4A).
Increase in the target transcript level after DRBD13 RNAi, suggestthat DRBD13 destabilizes RBP6 mRNA. Consistently, although
RBP6 steady state mRNA level is very low in the PC cells, we
detected a further reduction (1–2-fold down-regulation) of
RBP6 mRNA upon DRBD13 over-expression (Fig. 4B). A reduction
in RBP6 mRNA level in -tet with respect to the WT may reﬂect a
leaky expression of DRBD13-myc, which we did not detect on
the Western blot. Additionally, as already stated, a low level of
RBP6 mRNA might also have been responsible for the poor quanti-
tation of the radioactive signals. Together, these data suggest that
DRBD13 negatively regulates RBP6 mRNA.
3.4. Tethering assay suggests that DRBD13 destabilizes its bound
targets
We employed an RNA tethering approach to assess the possible
destabilizing role of DRBD13 on its targets. The experiment was
performed as described before [24]. Fig. 5A is a schematic repre-
sentation of the tethering experiment using two PC cell lines that
we generated. One cell line constitutively expressed a CAT mRNA
containing the ‘‘boxB’’ binding site for bacteriophage lambda N
Fig. 4. Effects of changes in DRBD13 level on RBP6 mRNA. (A) Northern blot showing changes in RBP6 mRNA level after DRBD13 knockdown. Top panel shows that the RBP6
mRNA is signiﬁcantly up-regulated after 24 h of DRBD13 RNAi. Histone H4mRNA (H4) was used as a loading control to measure the relative amounts of RBP6mRNA. Northern
blot also shows a successful DRDB13 RNAi. Bottom panel of the ﬁgure shows a quantitation of the blot. (B) Top panel shows a Northern blot for the RBP6 mRNA level changes
after DRBD13-myc expression. Similar to Fig. A, Histone H4 mRNA (H4) was used as a loading control to measure the relative amounts of RBP6 mRNA. The middle panel is a
Western blot showing the expression of DRBD13-myc. The blot was probed with anti-myc antibody and anti-PGK antibody (loading control). Bottom panel of the ﬁgure shows
a quantitation of the RBP6 mRNA levels similar to Fig. A.
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protein. A second cell line, which is used as control, constitutively
expressed the same CAT mRNA lacking the ‘‘boxB’’ but expressed
the inducible kN-DRBD13-myc protein. The 30 UTR used in the
CAT constructs was from the actin mRNA, which is unresponsive
to alterations in the DRBD13 expression. We also veriﬁed the cyto-
plasmic localization of the kN-DRBD13-myc (both tethered and
non-tethered) using anti-myc antibody (Fig. S1A). We next exam-
ined whether kN-DRBD13-myc fusion protein in these two cell
lines alters the CAT expression at both the mRNA and the protein
levels. When the cell line that constitutively expressed a CAT
mRNA containing the ‘‘boxB’’ and the kN-DRBD13-myc fusion pro-
tein was induced for 6, 12, 18, and 24 h, the CAT expression at both
the mRNA and the protein levels were signiﬁcantly reduced
(Fig. 5B and C; right panel). In contrast, in the control cell line in
the absence of boxB, induction of the kN-DRBD13-myc fusion pro-
tein did not lead to any changes in the CAT expression at either the
mRNA or protein levels (Fig. 5B and C; left panel). These data indi-
cate that the boxB-dependent binding of DRBD13 to 30 UTR of CAT
mRNA can lead to destabilization of the CAT reporter expression.
To assess whether or not DRBD13 is associated with the
polysome-bound mRNAs, extracts from DRBD13 over-expressing
cells were subjected to sucrose gradient fractionation and protein
distribution was monitored by Western blotting (Fig. S1B).
Consistent with the result of tethering assay, DRBD13 was detected
in the top fractions 1–3 which presumably represent
non-complexed soluble protein fractions away from the fractions
containing the small ribosomal protein S9, indicating that
DRBD13 is not associated with the actively translating mRNAs.We conclude that DRBD13 may have a destabilizing effect on its
target mRNAs. Nevertheless, we are aware that RBPs do not medi-
ate their regulatory function independent of the other regulators
and there is a complex combinatorial interaction network between
them. Therefore, it is possible by forcing the binding of an RBP to a
transcript that is not its natural target, the interacting partners of
the RBP and, consequently, the regulatory effect of the RBP
changes.
3.5. Changes in DRBD13 expression level resembles the cell surface
remodeling that occurs during the differentiation in the ﬂy
So far, our results suggest that expression of RBP6 and poten-
tially cell membrane proteins are regulated by DRBD13. To inves-
tigate the effect of DRBD13 on expression of membrane proteins,
we measured changes induced by DRBD13 on key cell membrane
proteins of PC and BS life stages. As representatives of these life
stages, we selected PC-speciﬁc GPEET2 procyclin [14] and VSG,
the major BS-speciﬁc surface coat protein. To monitor changes
induced by DRBD13 on the transcripts encoding these proteins,
we conducted two separate time-point experiments in DRBD13
knock-down and over-expression backgrounds. Intriguingly, we
found that GPEET2 is upregulated in response to DRBD13
knock-down, but VSG remained unchanged (Fig. 6A).
Consistently, GPEET2 was down-regulated by over-expression of
DRBD13, indicating the destabilizing role of DRBD13 on this impor-
tant PC cell surface glycoprotein (Fig. 6B). More interestingly, VSG
transcripts were detected after 24 h over-expression of DRBD13
(Fig. 6B). In MC life stage, VSG expression is mainly regulated by
Fig. 5. DRBD13 tethering causes a decrease in reporter mRNA level. (A) Schematic representation of the RNA tethering strategy. The fusion protein (kN-DRBD13-myc) does
not bind to the reporter mRNA lacking the recognition sequence for the kN peptide ‘‘boxB’’ in the reporter (left panel). Right panel shows the interaction between the fusion
protein ‘kN-DRBD13-myc’ and the reporter mRNA (mediated by boxB in the 30UTR). For simplicity only one stem loop structure has been shown in the reporter, although it
has 5 tandem boxB sequences. (B) Top panel shows a Western blot to detect the induction of the fusion protein kN-DRBD13-myc. Medium panel shows a down-regulation of
CAT expression at protein level in cell lines containing the reporter with boxB sequence (right lanes; 6 h onwards). Left lanes show no signiﬁcant effect on CAT levels after the
induction of the fusion protein in the cell line lacking boxB in the reporter mRNA. Bottom panel shows PGK signal which served as a loading control for the Western blot. WT-
wild type; ‘’ uninduced; ‘+’ induced. (C) Northern blot showing the effect of kN-DRBD13-myc tethering on CAT mRNA expression. Consistent with the Western blot, a
decrease in CAT mRNA can be seen after 6 h onwards (after tet addition) in cell lines with boxB containing reporter (right lanes). As expected, no effect was seen in the boxB
deﬁcient reporter’s expression (left lanes). Lower panel shows Histone H4 (H4) expression (loading control). WT – wild type; ‘’ uninduced; ‘+’ induced.
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whether the observed results is limited to the activation of the
metacyclic promoter, or the regulation has a more general effect,
we assessed the expression patterns of two other BS-speciﬁc cell
membrane-related proteins, ISG65 [29] and GPI-PLC [15]. Unlike
VSG, these two transcripts are expressed in a polycistronic manner
by RNA polymerase II. Therefore, putatively, there is no regulation
of these two transcripts at the transcriptional level. Consistent
with VSG expression pattern, we found that these two transcripts
encoding cell membrane-related proteins are also up-regulated in
DRBD13-myc over-expression background. Post-translational reg-
ulatory pathways play important roles in regulation of T. brucei dif-
ferentiation process [30–33], cell-membrane dynamics (including
the regulation of VSG [34] and ISG proteins [35]), and translation
[36]. Our RIP-seq experiment suggested preferential association
of DRBD13 protein with transcripts involved in post-translational
regulation. Therefore, DRBD13 might mediate its effect on the cell
by regulation of post-translational regulatory pathways. Overall,
these results indicate that expression of DRBD13 is correlated with
the expression of BS-speciﬁc cell coat proteins, but negatively cor-
related with those of PC life stage.
4. Conclusions
Recent progress in post-transcriptional gene regulation in T.
brucei and its critical role in development highlights the impor-
tance of RBPs and their interactions with cis-regulatory elements.A remarkable example of such regulation is when
over-expression of an ectopic RBP6 in PC trypanosomes led to
appearance of mammalian-infective MC forms expressing the
VSG coat [22]. However, the exact mechanism of these events is
unclear. Because DRBD13 associates with ARE containing tran-
scripts encoding surface coat proteins and RBP6 transcript is
among the signiﬁcantly enriched targets in DRBD13 RIP-seq data,
we sought to determine how changes in DRBD13 expression may
inﬂuence cell morphology and RBP6 mRNA. Signiﬁcantly, our
experiments revealed that DRBD13 acts as a negative regulator
for RBP6 and also major PC cell surface proteins like GPEET2.
However, more interestingly, the expression of DRBD13 is posi-
tively correlated with the appearance of BS-speciﬁc cell surface
genes such as VSG and ISG. To assess the biological relevance of
DRBD13 over-expression, we re-analyzed the T. brucei transcrip-
tome in infected tse-tse tissues [22]. Consistently, we found that
DRBD13 protein is up-regulated (2-fold up-regulation) in the
proventriculus life stage of the parasite. More interestingly, the
expression of RBP6 and procyclin transcripts are down-regulated
in the MC compared to the proventriculus life stage which can
be, at least partially, a delayed response to the over-expression of
DRBD13 transcript in the proventriculus life stage. Additionally,
the observed impairment between RBP6 and VSG expressions in
our experiments suggests that RBP6 is not the direct regulator of
VSG transcripts, and some intermediate factors are involved in
between. Overall, we speculate that DRBD13 is one of the major
regulators that coordinate the expression changes of at least cell
Fig. 6. DRBD13 mediates the cell surface remodeling of PC cells. (A) RNA was
isolated at various time points after DRBD13-RNAi induction. cDNA was prepared
using random primers followed by semi-quantitative reverse transcription PCR.
Over time, we observe a clear increase in the GPEET2 procyclin levels. However, no
change in expression of BS-speciﬁc VSG was observed. Histone H4 (H4) primers
were used for PCR to show equal amount and the quality of input cDNA. NTC- no
template control, WT – wild type; ‘’ uninduced; ‘+’ induced. (B) RNA was isolated
at various time points after DRBD13-myc induction. cDNA was prepared using
random primers followed by semi-quantitative reverse transcription PCR. A
prominent band showing VSG, ISG, and GPI-PLC expression in PC trypanosomes
was detectable after 18–24 h of DRBD13-myc induction. A clear decrease in the
GPEET2 procyclin levels can also be seen after 6 h of DRBD13-myc expression. At
later time points (16 and 25 days) GPEET2 procyclin expression becomes normal.
NTC – no template control, WT – wild type; ‘’ uninduced; ‘+’ induced. Histone H4
(H4) primers were used for PCR to show equal amount and the quality of input
cDNA.
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